315 related articles for article (PubMed ID: 34312684)
1. Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1.
Cheon SY; Cho K
J Mol Med (Berl); 2021 Nov; 99(11):1497-1509. PubMed ID: 34312684
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 signaling in hepatic lipid metabolism.
Han J; Wang Y
Protein Cell; 2018 Feb; 9(2):145-151. PubMed ID: 28434145
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-induced mTORC2-Akt-mTORC1 signaling promotes macrophage foam cell formation.
Banerjee D; Sinha A; Saikia S; Gogoi B; Rathore AK; Das AS; Pal D; Buragohain AK; Dasgupta S
Biochimie; 2018 Aug; 151():139-149. PubMed ID: 29883748
[TBL] [Abstract][Full Text] [Related]
4. Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases.
Kloska A; Węsierska M; Malinowska M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854299
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.
Zeng H; Yang K; Cloer C; Neale G; Vogel P; Chi H
Nature; 2013 Jul; 499(7459):485-90. PubMed ID: 23812589
[TBL] [Abstract][Full Text] [Related]
6. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.
Javary J; Allain-Courtois N; Saucisse N; Costet P; Heraud C; Benhamed F; Pierre R; Bure C; Pallares-Lupon N; Do Cruzeiro M; Postic C; Cota D; Dubus P; Rosenbaum J; Benhamouche-Trouillet S
Gut; 2018 Dec; 67(12):2192-2203. PubMed ID: 29074727
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health.
Wang G; Chen L; Qin S; Zhang T; Yao J; Yi Y; Deng L
Adv Nutr; 2022 Oct; 13(5):1882-1900. PubMed ID: 35561748
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Adipocyte and Macrophage Functions by mTORC1 and 2 in Metabolic Diseases.
Festuccia WT
Mol Nutr Food Res; 2021 Jan; 65(1):e1900768. PubMed ID: 32103588
[TBL] [Abstract][Full Text] [Related]
9. mTOR complex 1 signalling regulates the balance between lipid synthesis and oxidation in hypoxia lymphocytes.
Yin G; Liang Y; Wang Y; Yang Y; Yang M; Cen XM; Xie QB
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28057888
[TBL] [Abstract][Full Text] [Related]
10. Nutrient regulation of the mTOR complex 1 signaling pathway.
Kim SG; Buel GR; Blenis J
Mol Cells; 2013 Jun; 35(6):463-73. PubMed ID: 23694989
[TBL] [Abstract][Full Text] [Related]
11. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
12. The multifaceted role of mTORC1 in the control of lipid metabolism.
Ricoult SJ; Manning BD
EMBO Rep; 2013 Mar; 14(3):242-51. PubMed ID: 23399656
[TBL] [Abstract][Full Text] [Related]
13. A novel rapamycin analog is highly selective for mTORC1 in vivo.
Schreiber KH; Arriola Apelo SI; Yu D; Brinkman JA; Velarde MC; Syed FA; Liao CY; Baar EL; Carbajal KA; Sherman DS; Ortiz D; Brunauer R; Yang SE; Tzannis ST; Kennedy BK; Lamming DW
Nat Commun; 2019 Jul; 10(1):3194. PubMed ID: 31324799
[TBL] [Abstract][Full Text] [Related]
14. New Insights Into the Role of mTOR Signaling in the Cardiovascular System.
Sciarretta S; Forte M; Frati G; Sadoshima J
Circ Res; 2018 Feb; 122(3):489-505. PubMed ID: 29420210
[TBL] [Abstract][Full Text] [Related]
15. Molecular logic of mTORC1 signalling as a metabolic rheostat.
Valvezan AJ; Manning BD
Nat Metab; 2019 Mar; 1(3):321-333. PubMed ID: 32694720
[TBL] [Abstract][Full Text] [Related]
16. NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells.
Wang Y; Wan X; Hao Y; Zhao Y; Du L; Huang Y; Liu Z; Wang Y; Wang N; Zhang P
Cell Commun Signal; 2019 Jul; 17(1):77. PubMed ID: 31315616
[TBL] [Abstract][Full Text] [Related]
17. Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer.
Qian J; Chen Y; Meng T; Ma L; Meng L; Wang X; Yu T; Zask A; Shen J; Yu K
Oncotarget; 2016 Oct; 7(41):67071-67086. PubMed ID: 27563814
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling.
Lee G; Zheng Y; Cho S; Jang C; England C; Dempsey JM; Yu Y; Liu X; He L; Cavaliere PM; Chavez A; Zhang E; Isik M; Couvillon A; Dephoure NE; Blackwell TK; Yu JJ; Rabinowitz JD; Cantley LC; Blenis J
Cell; 2017 Dec; 171(7):1545-1558.e18. PubMed ID: 29153836
[TBL] [Abstract][Full Text] [Related]
19. Pathological Consequences of Hepatic mTORC1 Dysregulation.
Cho CS; Kowalsky AH; Lee JH
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32764389
[TBL] [Abstract][Full Text] [Related]
20. Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis.
Liao M; Hu F; Qiu Z; Li J; Huang C; Xu Y; Cheng X
Aging (Albany NY); 2021 Sep; 13(18):22412-22431. PubMed ID: 34547720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
